3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain, Postoperative
4
Pancreatic Neoplasms
2
Lung Neoplasms
2
Thoracic Neuritis
1
Stomach Neoplasms
1
Reperfusion Injury
1
Prostatic Neoplasms
1
Neoplasms
1
Liver Neoplasms
1
Inflammation
1
End Stage Liver Disease
1
Colonic Neoplasms
1
Breast Neoplasms
1
Bites and Stings
1
Agnosia
1
Acute Pain
1
Interventions
Exercise
5
Vitamin D
2
Tea
2
Sufentanil
2
Spironolactone
2
Probiotics
2
Oxycodone
2
Omeprazole
2
Morphine
2
Metformin
2
Etanercept
2
Colchicine
2
Ascorbic Acid
2
ziprasidone
1
soybean oil, phospholipid emulsion
1
salicylsalicylic acid
1
ginger extract
1
falcarinol
1
falcarindiol
1
epigallocatechin gallate
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Sulindac
1
Sodium Salicylate
1
Sodium Chloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Inflammation
×
Analgesia, Patient-Controlled
×
Clear all
NCT01367418
2012-03-19
AIMS
Örebro University, Sweden
Phase 3
Completed
26 enrolled